The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.

The high risk/reward ratio for drug development is the consequence of ... a leader in AI and analytics as a service for life science industries. With a background at Boston Consulting Group ...

Variations in regulatory requirements across regions often create inefficiencies in drug development—for example, differences in manufacturing standards and stability testing protocols can lead ...

Amid the ethical and legal arguments, a fundamental question remains: How much do we truly understand about the drugs used in ...

At least 42 volunteers had started a vaccine trial. Life-saving drug trials halted after unexpected move by US government: ...

Biotech company Valo Health and AI healthcare firm nference have entered into a multi-year partnership to leverage AI and ...

Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc.

Jindal served as governor of Louisiana and as a U.S. assistant secretary of Health and Human Services. Katebi is deputy director of the Center for a Healthy America at the America First Policy ...

The study was published in the journal Life Science Alliance on 11 February ... Phage display is a true 'golden goose' of drug development. It is a laboratory technique whose development earned ...